Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$19,364,956
+$12,187,638 QoQ
Shares Held
1,118,715
+93.7% QoQ
Ownership
0.350%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Derivatives in AMRX

reported options exposure · as of Jun 30, 2026
CallValue
$507,183
CallShares
29,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. AMRX ranks #10 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in AMRX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $507,183 29,300
2026-06-30 $19,364,956 1,118,715
2026-03-31 $522,060 42,000
2026-03-31 $7,177,318 577,419
2025-12-31 $77,814,285 6,175,737
2025-09-30 $234,234 23,400
2025-09-30 $57,350,282 5,729,299
2025-06-30 $835,697 103,300
2025-06-30 $45,503,677 5,624,682
2025-06-30 $96,271 11,900
2025-03-31 $62,783,202 7,492,029
2025-03-31 $460,900 55,000
2025-03-31 $438,274 52,300
2024-12-31 $4,752 600
2024-12-31 $464,904 58,700
2024-12-31 $71,129,266 8,980,968
2024-09-30 $18,304 2,200
2024-09-30 $78,208 9,400
2024-09-30 $73,983,877 8,892,293
2024-06-30 $63,428,403 9,988,725
2024-06-30 $66,675 10,500
2024-06-30 $17,145 2,700
2024-03-31 $30,708,946 5,067,483
2024-03-31 $99,384 16,400
2024-03-31 $1,818 300
2023-12-31 $39,437,336 6,497,090
2023-12-31 $40,062 6,600
2023-12-31 $92,264 15,200
2023-09-30 $11,346,440 2,688,730
2023-09-30 $7,596 1,800
2023-09-30 $35,026 8,300
2023-06-30 $18,290 5,900
2023-06-30 $14,880 4,800
2023-06-30 $3,706,074 1,195,508
2023-03-31 $28,634 20,600
2023-03-31 $1,438,931 1,035,203
2023-03-31 $7,784 5,600
2022-12-31 $1,372,609 689,754
2022-12-31 $30,646 15,400
2022-12-31 $43,183 21,700
2022-09-30 $113,524 56,200
2022-09-30 $3,326,117 1,646,593
2022-06-30 $4,559,769 1,433,890
2022-06-30 $185,712 58,400
2022-03-31 $6,109,549 1,465,120
2022-03-31 $295,236 70,800
2022-03-31 $153,039 36,700
2021-12-31 $7,644,586 1,595,947
2021-12-31 $85,741 17,900
2021-12-31 $406,192 84,800